Author: Ágnes Kovács1,2
View More View Less
  • 1 Corvinus University of Budapest
  • | 2 Astellas Pharma Hungary, Csörsz u. 49-51. H-1124 Budapest, Hungary
Restricted access

The paper provides a systematic review on the cost-of-illness studies in an age-associated condition with high prevalence, benign prostatic hyperplasia (BPH), published in Medline between 2005 and 2015. Overall 11 studies were included, which were conducted in 8 countries. In the US, the annual direct medical costs per patient ranged from $255 to $5,729, while in Europe from €253 to €1,251. In 2008, in the UK total annual direct medical costs of BPH were £180.8 million at national level. In the US, overall costs of BPH management in the private sector were estimated at $3.9 billion annually, of which $500 million was attributable to productivity loss (year 1999). Due to demographic factors and possible surgical innovations in the field of urology, the costs of BPH are likely to increase in the future. Over the next decade the age of retirement is projected to rise, consequently, the indirect costs related to aging-associated conditions such as BPH are expected to soar. To promote the transparent and cost-effective management of BPH, development of rational clinical guidelines would be essential that may lead to significant improvement in quality of care as well as reduction in healthcare expenditure.

  • Average effective age of retirement versus the official age in 2012 in OECD countries (2012): http://www.oecd.org/els/emp/Summary_2012_values.xls. Accessed: 07.05.2015.

  • Bellinger, A.S.Elliott, S.P.Yang, L.Wei, J.T.Saigal, C.S.Smith, A.Wilt, T.J.Strope, S.A. (2012): Changes in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflation. Journal of Urology 187(5): 17391746.

    • Search Google Scholar
    • Export Citation
  • Boncz, I.Vajda, R.Agoston, I.Endrei, D.Sebestyen, A. (2014): Changes in the health status of the population of Central and Eastern European countries between 1990 and 2010. European Journal of Health Economics 15(1): 137141.

    • Search Google Scholar
    • Export Citation
  • Brodszky, V.Balint, P.Geher, P.Hodinka, L.Horvath, G.Koo, E.Pentek, M.Polgar, A.Sesztak, M.Szanto, S.Ujfalussy, I.Gulacsi, L. (2009): Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment. Rheumatology International 30(2): 199205.

    • Search Google Scholar
    • Export Citation
  • Commission of the European Communities. Regions 2020 – demographic challenges for European regions (2008): ec.europa.eu/regional_policy/sources/docoffic/working/regions2020/pdf/ regions2020_demographic.pdf. Accessed: 07.05.2015.

  • Cozar, J.M.Huerta, A. (2013): Care management of patients with benign prostatic hyperplasia in Spain [Manejo asistencial del paciente con hiperplasia benigna de próstata en España].. Actas Urológicas Españolas–English edition 37(1): 6061.

    • Search Google Scholar
    • Export Citation
  • DiSantostefano, R.L. - Biddle, A.K.Lavelle, J.P. (2006): An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia. BJU International 97(5):10071016.

    • Search Google Scholar
    • Export Citation
  • Emberton, M.Anson, K. (1999): Acute urinary retention in men: an age old problem. British Medical Journal 318(7188): 921925.

  • Ersek, K.Kovacs, T.Wimo, A.Karpati, K.Brodszky, V.Pentek, M.Jonsson, L.Gustavsson, A.McDaid, D.Kenigsberg, P.A.Valtonen, H.Gulacsi, L. (2010): Costs of dementia in Hungary. The Journal of Nutrition Health and Aging 14(8): 633639.

    • Search Google Scholar
    • Export Citation
  • Fourcade, R.O.Lacoin, F.Roupret, M.Slama, A.Le Fur, C.Michel, E.Sitbon, A.Cotte, F.E. (2012): Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. World Journal of Urology 30(3): 419426.

    • Search Google Scholar
    • Export Citation
  • Gulacsi, L.Pentek, M. (2014a): HTA in Central and Eastern European countries; the 2001: a space odyssey and efficiency gain. European Journal of Health Economics 15(7):675680.

    • Search Google Scholar
    • Export Citation
  • Gulacsi, L.Rencz, F.Pentek, M.Brodszky, V.Lopert, R.Hever, N.V.Baji, P. (2014b): Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries. European Journal of Health Economics 15(1): 2734.

    • Search Google Scholar
    • Export Citation
  • Gulacsi, L.Rotar, A.M.Niewada, M.Loblova, O.Rencz, F.Petrova, G.Boncz, I.Klazinga, N.S. (2014c): Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria. European Journal of Health Economics 15(1): 1325.

    • Search Google Scholar
    • Export Citation
  • Heredi, E.Rencz, F.Balogh, O.Gulacsi, L.Herszenyi, K.Hollo, P.Jokai, H.Karpati, S.Pentek, M.Remenyik, E.Szegedi, A.Brodszky, V. (2014): Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary. European Journal of Health Economics 15(1): 111119.

    • Search Google Scholar
    • Export Citation
  • Hever, N.V.Pentek, M.Ballo, A.Gulacsi, L.Baji, P.Brodszky, V.Damasdi, M.Bognar, Z.Toth, G.Buzogany, I.Szanto, A. (2014): Health Related Quality of Life in Patients with Bladder Cancer: A Cross-Sectional Survey and Validation Study of the Hungarian Version of the Bladder Cancer Index. Pathology and Oncology Research.

    • Search Google Scholar
    • Export Citation
  • Johansen, T.E.Istad, J.A. (2007): Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway. Scandinavian journal of urology and nephrology 41(2): 124131.

    • Search Google Scholar
    • Export Citation
  • Kirby, R.S.Kirby, M.Fitzpatrick, J.M. (2010): Benign prostatic hyperplasia: counting the cost of its management. BJU International 105(7): 901902.

    • Search Google Scholar
    • Export Citation
  • Litwin, M.S.Saigal, C.S.Yano, E.M.Avila, C.Geschwind, S.A.Hanley, J.M.Joyce, G.F.Madison, R.Pace, J.Polich, S.M.Wang, M. (2005): Urologic diseases in America Project: analytical methods and principal findings. Journal of Urology 173(3): 933937.

    • Search Google Scholar
    • Export Citation
  • Moradi, M.Rencz, F.Brodszky, V.Moradi, A.Balogh, O.Gulacsi, L. (2015): Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey. Archives of Iranian Medicine 18(3): 153159.

    • Search Google Scholar
    • Export Citation
  • Pentek, M.Bereczki, D.Gulacsi, L.Mikudina, B.Aranyi, Z.Juhos, V.Baji, P.Brodszky V. (2013): Survey of adults living with epilepsy in Hungary: health-related quality of life and costs [Epilepsziával élő felnőttek felmérése Magyarországon: életminőség és költségek]. Ideggyógyászati Szemle 66(7-8): 251261.

    • Search Google Scholar
    • Export Citation
  • Pentek, M.Horvath, C.Boncz, I.Falusi, Z.Toth, E.Sebestyen, A.Majer, I.Brodszky, V.Gulacsi, L. (2008): Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999–2003. Osteoporos International 19(2): 243249.

    • Search Google Scholar
    • Export Citation
  • Rencz, F. (2012): Health economics analysis of benign prostatic hyperplasia [A jóindulatú prosztata– megnagyobbodás egészség–gazdaságtani elemzése].. Köz–Gazdaság 7(3): 135151.

    • Search Google Scholar
    • Export Citation
  • Rencz, F.Brodszky, V.Péntek, M.Balogh, O.Remenyik, É.Szegedi, A.Holló, P.Kárpáti, S.Jókai, H.Herszényi, K.Herédi, E.Szántó, S.Gulácsi, L. (2014a): Disease burden of psoriasis associated with psoriatic arthritis in Hungary[Arthritis psoriaticával társuló középsúlyos és súlyos psoriasis betegségterhe Magyarországon]. Orvosi Hetilap 155(48): 19131921.

    • Search Google Scholar
    • Export Citation
  • Rencz, F.Brodszky, V.Pentek, M.Bereczki, D.Gulacsi, L. (2015a): Health state utilities for migraine based on attack frequency: a time trade-off study. Neurological Sciences 36(2): 197202.

    • Search Google Scholar
    • Export Citation
  • Rencz, F.Brodszky, V.Varga, P.Gajdacsi, J.Nyirady, P.Gulacsi, L. (2014b): The economic burden of prostate cancer. A systematic literature overview of registry-based studies [A prosztata r¨¢k gazdas¨¢gi terhe nagy betegregiszterek alapjñ]. Orvosi Hetilap 155(13): 509520.

    • Search Google Scholar
    • Export Citation
  • Rencz, F.Gulacsi, L.Tamasi, B.Karpati, S.Pentek, M.Baji, P.Brodszky, V. (2015b): Health related quality of life and its determinants in pemphigus: a systematic review and meta- analysis. British Journal of Dermatology.

    • Search Google Scholar
    • Export Citation
  • Rencz, F.Hollo, P.Karpati, S.Pentek, M.Remenyik, E.Szegedi, A.Balogh, O.Heredi, E.Herszenyi, K.Jokai, H.Brodszky, V.Gulacsi, L. (2014c): Moderate to severe psoriasis patients’ subjective future expectations regarding health-related quality of life and longevity. Journal of the European Academy of Dermatology and Venereology.

    • Search Google Scholar
    • Export Citation
  • Rosen, R.Altwein, J.Boyle, P.Kirby, R.S.Lukacs, B.Meuleman, E.O’Leary, M.P.Puppo, P.Robertson, C.Giuliano, F. (2003): Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). European Urology 44(6): 637649.

    • Search Google Scholar
    • Export Citation
  • Saigal, C.S.Joyce, G. (2005): Economic costs of benign prostatic hyperplasia in the private sector. Journal of Urology 173(4): 13091313.

    • Search Google Scholar
    • Export Citation
  • Saigal, C.S.Movassaghi, M.Pace, J.Joyce, G. (2007): Economic evaluation of treatment strategies for benign prostatic hyperplasia--is medical therapy more costly in the long run? Journal of Urology 177(4): 14631467. discussion 1467.

    • Search Google Scholar
    • Export Citation
  • Schulz, M.W.Chen, J.Woo, H.H.Keech, M.Watson, M.E.Davey, P.J. (2002): A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia. Journal of Urology 168(1):155159.

    • Search Google Scholar
    • Export Citation
  • Shrestha, L.B. (2000): Population aging in developing countries. Health Affairs (Millwood) 19(3): 20412.

  • Speakman, M.Kirby, R.Doyle, S.Ioannou, C. (2014): Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU International.

    • Search Google Scholar
    • Export Citation
  • Strope, S.A.Elliott, S.P.Smith, A.Wei, J.T.Wilt, T.J.Saigal, C.S. (2011): Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia. Urology 77(3): 535540.

    • Search Google Scholar
    • Export Citation
  • Tamas, G.Gulacsi, L.Bereczki, D.Baji, P.Takats, A.Brodszky, V.Pentek, M. (2014): Quality of life and costs in Parkinson’s disease: a cross sectional study in Hungary. PLoS One 9(9): e107704.

    • Search Google Scholar
    • Export Citation
  • Taub, D.A.Wei, J.T. (2006): The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Current Urology Reports 7(4): 272281.

    • Search Google Scholar
    • Export Citation
  • The 2012 Ageing Report. Economic and Budgetary Projections for the 27 EU Member States (2010–2060). http://ec.europa.eu/economy_finance/publications/european_economy/2012/pdf/ ee-2012-2_en.pdf. Accessed: 07.05.2015.

  • van Exel, N.J.Koopmanschap, M.A.McDonnell, J.Chapple, C.R.Berges, R.Rutten, F.F. (2006): Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH study. European Urology 49(1): 92102.

    • Search Google Scholar
    • Export Citation
  • Wei, J.T.Calhoun, E.Jacobsen, S.J. (2005): Urologic diseases in America project: benign prostatic hyperplasia. Journal of Urology 173(4): 12561261.

    • Search Google Scholar
    • Export Citation
The author instruction is available in PDF.
Please, download the file from HERE.
 
The Open Access statement together with the description of the Copyright and License Policy are available in PDF.
Please, download the file from HERE.

Editor-in-chief: Balázs SZENT-IVÁNYI

Co-Editors:

  • Péter MARTON (Corvinus University, Budapest)
  • István KÓNYA (Corvinus University, Budapest)
  • László SAJTOS (The University of Auckland)
  • Gábor VIRÁG (University of Toronto)

Associate Editors:

  • Tamás BOKOR (Corvinus University, Budapest)
  • Sándor BOZÓKI (Corvinus University Budapest)
  • Bronwyn HOWELL (Victoria University of Wellington)
  • Hintea CALIN (Babeş-Bolyai University)
  • Christian EWERHART (University of Zürich)
  • Clemens PUPPE (Karlsruhe Institute of Technology)
  • Zsolt DARVAS (Bruegel)
  • Szabina FODOR (Corvinus University Budapest)
  • Sándor GALLAI (Corvinus University Budapest)
  • László GULÁCSI (Óbuda University)
  • Dóra GYŐRFFY (Corvinus University Budapest)
  • György HAJNAL (Corvinus University Budapest)
  • Krisztina KOLOS (Corvinus University Budapest)
  • Alexandra KÖVES (Corvinus University Budapest)
  • Lacina LUBOR (Mendel University in Brno)
  • Péter MEDVEGYEV (Corvinus University Budapest)
  • Miroslava RAJČÁNIOVÁ (Slovak University of Agriculture)
  • Ariel MITEV (Corvinus University Budapest)
  • Éva PERPÉK (Corvinus University Budapest)
  • Petrus H. POTGIETER (University of South Africa)
  • Sergei IZMALKOV (MIT Economics)
  • Anita SZŰCS (Corvinus University Budapest)
  • László TRAUTMANN (Corvinus University Budapest)
  • Trenton G. SMITH (University of Otago)
  • György WALTER (Corvinus University Budapest)
  • Zoltán CSEDŐ (Corvinus University Budapest)
  • Zoltán LŐRINCZI (Ministry of Human Capacities)

Society and Economy
Institute: Corvinus University of Budapest
Address: Fővám tér 8. H-1093 Budapest, Hungary
Phone: (36 1) 482 5406
E-mail: balazs.szentivanyi@uni-corvinus.hu

Indexing and Abstracting Services:

  • DOAJ
  • International Bibliographies IBZ and IBR
  • International Political Science Abstracts
  • JSTOR
  • SCOPUS
  • RePEc
  • Referativnyi Zhurnal

 

2020  
Scimago
H-index
11
Scimago
Journal Rank
0,157
Scimago
Quartile Score
Business and International Management Q4
Economics, Econometrics and Finance (miscellaneous) Q4
Industrial Relations Q4
Public Administration Q4
Sociology and Political Science Q3
Strategy and Management Q4
Scopus
Cite Score
103/117=0,9
Scopus
Cite Score Rank
Business and International Management 305/399 (Q4)
General Economics, Econometrics and Finance 137/243 (Q3)
Industrial Relations 40/54 (Q3)
Public Administration 116/165 (Q3)
Sociology and Political Science 665/1269 (Q3)
Strategy and Management 351/440 (Q4)
Scopus
SNIP
0,171
Scopus
Cites
157
Scopus
Documents
24
Days from submission to acceptance 148
Days from acceptance to publication 50

 

2019  
Scimago
H-index
10
Scimago
Journal Rank
0,228
Scimago
Quartile Score
Business and International Management Q3
Economics, Econometrics and Finance (miscellaneous) Q3
Industrial Relations Q3
Public Administration Q3
Sociology and Political Science Q3
Strategy and Management Q3
Scopus
Cite Score
87/110=0,8
Scopus
Cite Score Rank
Business and International Management 286/394 (Q3)
General Economics, Econometrics and Finance 125/228 (Q3)
Industrial Relations 38/58 (Q3)
Public Administration 114/157 (Q3)
Sociology and Political Science 645/1243 (Q3)
Strategy and Management 330/427 (Q4)
Scopus
SNIP
0,308
Scopus
Cites
132
Scopus
Documents
22

 

Society and Economy
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge 900 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Sufficient number of full waiver available. Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

Society and Economy
Language English
Size B5
Year of
Foundation
1972
Publication
Programme
2021 Volume 43
Volumes
per Year
1
Issues
per Year
4
Founder Budapesti Corvinus Egyetem
Founder's
Address
H-1093 Budapest, Hungary Fővám tér 8.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1588-9726 (Print)
ISSN 1588-970X (Online)